AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
1-Year Est. Return 6.63%
This Quarter Est. Return
1 Year Est. Return
+6.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$950M
AUM Growth
-$134M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
16
New
Increased
Reduced
Closed

Top Buys

1
+$10M
2
+$605K

Top Sells

1
+$1.29M
2
+$1.07M
3
+$804K
4
JBIO
Jade Biosciences
JBIO
+$398K
5
SPRO icon
Spero Therapeutics
SPRO
+$94K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$283M 29.8%
8,020,136
2
$160M 16.82%
5,350,422
-26,940
3
$142M 14.93%
10,907,859
4
$113M 11.91%
2,509,456
+222,223
5
$88.6M 9.33%
6,430,257
6
$38.5M 4.06%
1,137,149
+17,857
7
$37.6M 3.95%
2,092,106
8
$23.3M 2.46%
827,948
9
$23.3M 2.46%
5,836,874
10
$18.9M 1.99%
2,098,300
11
$8.28M 0.87%
418,182
12
$6.23M 0.66%
378,447
-1
13
$3.55M 0.37%
136,979
-50,000
14
$2.99M 0.31%
51,407
-6,857
15
$696K 0.07%
535,336
-72,277
16
– –
-992,912